The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
The Roles of MicroRNA in Lung Cancer
Open accessAbstract
Lung cancer is the most devastating malignancy in the world. Beyond genetic research, epigenomic studies—especially investigations of microRNAs—have grown rapidly in quantity and quality in the past decade. This has enriched our understanding about basic cancer biology and lit up the opportunities for potential therapeutic development. In this review, we summarize the involvement of microRNAs in lung cancer carcinogenesis and behavior, by illustrating the relationship to each cancer hallmark capability, and in addition, we briefly describe the clinical applications of microRNAs in lung cancer diagnosis and prognosis. Finally, we discuss the potential therapeutic use of microRNAs in lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
5 retracted
Garofalo, M., Romano, G., Di Leva, G., Nuovo, G., Jeon, Y.-J., Ngankeu, A., Sun, J., Lovat, F., Alder, H., Condorelli, G., et al. (2012) · Nature Medicine · doi:10.1038/nm.2577 · Cited by 365
RetractedRen, P., Gong, F., Zhang, Y., Jiang, J., & Zhang, H. (2015) · Tumor Biology · doi:10.1007/s13277-015-4150-3 · Cited by 78
RetractedYang, L., Yang, J., Li, J., Shen, X., Le, Y., Zhou, C., Wang, S., Zhang, S., Xu, D., & Gong, Z. (2015) · Scientific Reports · doi:10.1038/srep13677 · Cited by 67
RetractedmiR-641 Functions as a Tumor Suppressor by Targeting MDM2 in Human Lung Cancer
Kong, Q., Shu, N., Jun, L., & Xu, N. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x15021536183490 · Cited by 51
RetractedWang, W., Chen, J., Dai, J., Zhang, B., Wang, F., & Sun, Y. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14685034103194 · Cited by 19
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
The nuclear RNase III Drosha initiates microRNA processing
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S., et al. (2003) · Nature · doi:10.1038/nature01957 · Cited by 5,114
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
The Microprocessor complex mediates the genesis of microRNAs
Gregory, R. I., Yan, K.-P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., & Shiekhattar, R. (2004) · Nature · doi:10.1038/nature03120 · Cited by 2,742
Nuclear Export of MicroRNA Precursors
Lund, E., Güttinger, S., Calado, A., Dahlberg, J. E., & Kutay, U. (2004) · Science · doi:10.1126/science.1090599 · Cited by 2,714
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0637 · Cited by 2,354
Treatment of HCV Infection by Targeting MicroRNA
Janssen, H. L. A., Reesink, H. W., Lawitz, E. J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,204
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
Shaw, A. T., Yeap, B. Y., Mino-Kenudson, M., Digumarthy, S. R., Costa, D. B., Heist, R. S., Solomon, B., Stubbs, H., Admane, S., McDermott, U., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6993 · Cited by 1,870
Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707628104 · Cited by 1,673
Tobacco smoking and cancer: A meta‐analysis
Gandini, S., Botteri, E., Iodice, S., Boniol, M., Lowenfels, A. B., Maisonneuve, P., & Boyle, P. (2008) · International Journal of Cancer · doi:10.1002/ijc.23033 · Cited by 971
Chen, L., Gibbons, D. L., Goswami, S., Cortez, M. A., Ahn, Y.-H., Byers, L. A., Zhang, X., Yi, X., Dwyer, D., Lin, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6241 · Cited by 966
Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells
Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setién, F., Casado, S., Suarez-Gauthier, A., Sanchez-Cespedes, M., Gitt, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4218 · Cited by 939
Beg, M. S., Brenner, A. J., Sachdev, J., Borad, M., Kang, Y.-K., Stoudemire, J., Smith, S., Bader, A. G., Kim, S., & Hong, D. S. (2017) · Investigational New Drugs · doi:10.1007/s10637-016-0407-y · Cited by 897
Carmell, M. A., Xuan, Z., Zhang, M. Q., & Hannon, G. J. (2002) · Genes & Development · doi:10.1101/gad.1026102 · Cited by 883
Cellular abnormalities of blood vessels as targets in cancer
Baluk, P., Hashizume, H., & McDonald, D. M. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.005 · Cited by 781
van Zandwijk, N., Pavlakis, N., Kao, S. C., Linton, A., Boyer, M. J., Clarke, S., Huynh, Y., Chrzanowska, A., Fulham, M. J., Bailey, D. L., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30621-6 · Cited by 710
miRNA Deregulation in Cancer Cells and the Tumor Microenvironment
Rupaimoole, R., Calin, G. A., Lopez-Berestein, G., & Sood, A. K. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0893 · Cited by 689
PDL1 Regulation by p53 via miR-34
Cortez, M. A., Ivan, C., Valdecanas, D., Wang, X., Peltier, H. J., Ye, Y., Araujo, L., Carbone, D. P., Shilo, K., Giri, D. K., et al. (2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv303 · Cited by 683
Hsu, Y.-L., Hung, J.-Y., Chang, W.-A., Lin, Y.-S., Pan, Y.-C., Tsai, P.-H., Wu, C.-Y., & Kuo, P.-L. (2017) · Oncogene · doi:10.1038/onc.2017.105 · Cited by 597
Self-citationInhibition of microRNA function by antimiR oligonucleotides
Stenvang, J., Petri, A., Lindow, M., Obad, S., & Kauppinen, S. (2012) · Silence · doi:10.1186/1758-907x-3-1 · Cited by 560
Morgensztern, D., Ng, S. H., Gao, F., & Govindan, R. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c5920c · Cited by 547
Lung carcinogenesis by tobacco smoke
Hecht, S. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27816 · Cited by 480
Sozzi, G., Boeri, M., Rossi, M., Verri, C., Suatoni, P., Bravi, F., Roz, L., Conte, D., Grassi, M., Sverzellati, N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.4357 · Cited by 436
P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis
Yamakuchi, M., Lotterman, C. D., Bao, C., Hruban, R. H., Karim, B., Mendell, J. T., Huso, D., & Lowenstein, C. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911082107 · Cited by 430
Lebanony, D., Benjamin, H., Gilad, S., Ezagouri, M., Dov, A., Ashkenazi, K., Gefen, N., Izraeli, S., Rechavi, G., Pass, H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.4134 · Cited by 408
Tumour angiogenesis regulation by the miR-200 family
Pecot, C. V., Rupaimoole, R., Yang, D., Akbani, R., Ivan, C., Lu, C., Wu, S., Han, H.-D., Shah, M. Y., Rodriguez-Aguayo, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3427 · Cited by 402
Bandi, N., Zbinden, S., Gugger, M., Arnold, M., Kocher, V., Hasan, L., Kappeler, A., Brunner, T., & Vassella, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4277 · Cited by 386
Molecular Pathways: ROS1 Fusion Proteins in Cancer
Davies, K. D., & Doebele, R. C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2851 · Cited by 373
Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers
Kyo, S., Takakura, M., Fujiwara, T., & Inoue, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00878.x · Cited by 347
Control of Developmental Timing by MicroRNAs and Their Targets
Pasquinelli, A. E., & Ruvkun, G. (2002) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.18.012502.105832 · Cited by 341
Liu, B., Peng, X.-C., Zheng, X.-L., Wang, J., & Qin, Y.-W. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.01.010 · Cited by 326
miR-Test: A Blood Test for Lung Cancer Early Detection
Montani, F., Marzi, M. J., Dezi, F., Dama, E., Carletti, R. M., Bonizzi, G., Bertolotti, R., Bellomi, M., Rampinelli, C., Maisonneuve, P., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv063 · Cited by 278
Fujita, Y., Yagishita, S., Hagiwara, K., Yoshioka, Y., Kosaka, N., Takeshita, F., Fujiwara, T., Tsuta, K., Nokihara, H., Tamura, T., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.10 · Cited by 261
K-ras as a target for cancer therapy
Friday, B. B., & Adjei, A. A. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.001 · Cited by 241
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
Larrea, E., Sole, C., Manterola, L., Goicoechea, I., Armesto, M., Arestin, M., Caffarel, M., Araujo, A., Araiz, M., Fernandez-Mercado, M., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050627 · Cited by 239
Overview upon miR-21 in lung cancer: focus on NSCLC
Bica-Pop, C., Cojocneanu-Petric, R., Magdo, L., Raduly, L., Gulei, D., & Berindan-Neagoe, I. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2877-x · Cited by 236
Hepatocellular carcinoma and microRNA: New perspectives on therapeutics and diagnostics
Yang, N., Ekanem, N. R., Sakyi, C. A., & Ray, S. D. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.029 · Cited by 230
Yang, M., Shen, H., Qiu, C., Ni, Y., Wang, L., Dong, W., Liao, Y., & Du, J. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.031 · Cited by 226
Genomic Instability and Cancer
Wei Dai, Y. Y. (2014) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000165 · Cited by 225
Accurate Classification of Non–Small Cell Lung Carcinoma Using a Novel MicroRNA-Based Approach
Bishop, J. A., Benjamin, H., Cholakh, H., Chajut, A., Clark, D. P., & Westra, W. H. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2638 · Cited by 223
MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines
Grosso, S., Doyen, J., Parks, S. K., Bertero, T., Paye, A., Cardinaud, B., Gounon, P., Lacas-Gervais, S., Noël, A., Pouysségur, J., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.71 · Cited by 216
MicroRNA regulons in tumor microenvironment
Suzuki, H. I., Katsura, A., Matsuyama, H., & Miyazono, K. (2015) · Oncogene · doi:10.1038/onc.2014.254 · Cited by 209
Pathogenesis of lung cancer signalling pathways: roadmap for therapies
Brambilla, E., & Gazdar, A. (2009) · European Respiratory Journal · doi:10.1183/09031936.00014009 · Cited by 205
The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
Titze-de-Almeida, R., David, C., & Titze-de-Almeida, S. S. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2134-2 · Cited by 200
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
Cortez, M. A., Valdecanas, D., Zhang, X., Zhan, Y., Bhardwaj, V., Calin, G. A., Komaki, R., Giri, D. K., Quini, C. C., Wolfe, T., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.79 · Cited by 196
Kitamura, K., Seike, M., Okano, T., Matsuda, K., Miyanaga, A., Mizutani, H., Noro, R., Minegishi, Y., Kubota, K., & Gemma, A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0448 · Cited by 187
New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications
Wang, Y., Wang, L., Chen, C., & Chu, X. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0766-4 · Cited by 178
Li, B., Ren, S., Li, X., Wang, Y., Garfield, D., Zhou, S., Chen, X., Su, C., Chen, M., Kuang, P., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.003 · Cited by 177
Langevin, S. M., Kratzke, R. A., & Kelsey, K. T. (2015) · Translational Research · doi:10.1016/j.trsl.2014.03.001 · Cited by 173
Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer
Mao, G., Liu, Y., Fang, X., Liu, Y., Fang, L., Lin, L., Liu, X., & Wang, N. (2015) · Angiogenesis · doi:10.1007/s10456-015-9474-5 · Cited by 171
Role of specific microRNAs for endothelial function and angiogenesis
Wu, F., Yang, Z., & Li, G.-H. (2009) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2009.06.075 · Cited by 165
Cancer Hallmarks and MicroRNAs: The Therapeutic Connection
(2017) · Advances in Cancer Research · doi:10.1016/bs.acr.2017.06.002 · Cited by 164
Hu, J., Cheng, Y., Li, Y., Jin, Z., Pan, Y., Liu, G., Fu, S., Zhang, Y., Feng, K., & Feng, Y. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.06.005 · Cited by 160
An overview of viral and nonviral delivery systems for microRNA
Yang, N. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.167646 · Cited by 149
Li, J., Wang, Y., Song, Y., Fu, Z., & Yu, W. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-193 · Cited by 139
Classification of the Four Main Types of Lung Cancer Using a MicroRNA-Based Diagnostic Assay
Gilad, S., Lithwick‐Yanai, G., Barshack, I., Benjamin, S., Krivitsky, I., Edmonston, T. B., Bibbo, M., Thurm, C. A., Horowitz, L., Huang, Y., et al. (2012) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.03.004 · Cited by 138
miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer
Nishikawa, E., Osada, H., Okazaki, Y., Arima, C., Tomida, S., Tatematsu, Y., Taguchi, A., Shimada, Y., Yanagisawa, K., Yatabe, Y., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1020 · Cited by 138
Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin
Rosenwald, S., Gilad, S., Benjamin, S., Lebanony, D., Dromi, N., Faerman, A., Benjamin, H., Tamir, R., Ezagouri, M., Goren, E., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.57 · Cited by 135
Kasiappan, R., Shen, Z., Tse, A. K., Jinwal, U. K., Tang, J., Lungchukiet, P., Sun, Y., Kruk, P. A., Nicosia, S. V., Zhang, X. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407189 · Cited by 127
MicroRNA Targeting to Modulate Tumor Microenvironment
Kuninty, P. R., Schnittert, J., Storm, G., & Prakash, J. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00003 · Cited by 125
Regulation of Vascular Endothelial Growth Factor Signaling by miR-200b
Choi, Y.-C., Yoon, S., Jeong, Y., Yoon, J., & Baek, K. (2011) · Molecules and Cells · doi:10.1007/s10059-011-1042-2 · Cited by 122
Buro-Auriemma, L. J., Salit, J., Hackett, N. R., Walters, M. S., Strulovici‐Barel, Y., Staudt, M. R., Fuller, J. A., Mahmoud, M., Stevenson, C. S., Hilton, H., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt326 · Cited by 117
Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer
Shen, H., Zhu, F., Liu, J., Xu, T., Pei, D., Wang, R., Qian, Y., Li, Q., Wang, L., Shi, Z., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103305 · Cited by 116
Sundar, I. K., Nevid, M. Z., Friedman, A. E., & Rahman, I. (2013) · Journal of Proteome Research · doi:10.1021/pr400998n · Cited by 115
Wang, Y.-S., Wang, Y., Xia, H., Zhou, S., Schmid‐Bindert, G., & Zhou, C. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.1.255 · Cited by 115
Yue, J., Lv, D., Wang, C., Li, L., Zhao, Q., Chen, H., & Xu, L. (2018) · Oncogene · doi:10.1038/s41388-018-0276-2 · Cited by 107
A MicroRNA Cluster at 14q32 Drives Aggressive Lung Adenocarcinoma
Nadal, E., Zhong, J., Lin, J., Reddy, R. M., Ramnath, N., Orringer, M. B., Chang, A. C., Beer, D. G., & Chen, G. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3348 · Cited by 106
MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer
Dønnem, T., Fenton, C. G., Lønvik, K., Berg, T., Eklo, K., Andersen, S., Stenvold, H., Al-Shibli, K. I., Al‐Saad, S., Bremnes, R. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029671 · Cited by 105
Zhou, G., Fangli, Z., Yu, G., Huang, J., Xie, Y., Yue, S., Chen, M., Jiang, H., & Li, M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.100 · Cited by 102
MicroRNA expression differentiates between primary lung tumors and metastases to the lung.
Barshack, I., Lithwick-Yanai, G., Afek, A., Rosenblatt, K., Tabibian-Keissar, H., Zepeniuk, M., Cohen, L., Dan, H., Zion, O., Strenov, Y., et al. (2010) · Pathology, Research and Practice · doi:10.1016/j.prp.2010.03.005 · Cited by 91
Ren, X., Yin, M., Zhang, X., Wang, Z., Feng, S., Wang, G., Luo, Y., Liang, P., Yang, X., He, J., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.10.031 · Cited by 91
Zhu, K., Ding, H., Wang, W., Liao, Z., Fu, Z., Hong, Y., Zhou, Y., Zhang, C., & Chen, X. (2016) · Oncotarget · doi:10.18632/oncotarget.8576 · Cited by 91
European Code against Cancer, 4th Edition: Tobacco and cancer
Leon, M. E., Peruga, A., McNeill, A. D., Králíková, E., Guha, N., Minozzi, S., Espina, C., & Schüz, J. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.06.001 · Cited by 90
Zhao, W., Wang, Y., An, Z.-J., Chang-guo, S., Zhu, G.-A., Wang, B., Lu, M.-Y., Pan, C., & Chen, P. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.010 · Cited by 90
Zhao, Z., Zhang, L., Yao, Q., & Tao, Z. (2015) · Cancer Gene Therapy · doi:10.1038/cgt.2014.73 · Cited by 86
Up- regulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy
Ma, W., Ma, C., Zhou, N., Li, X.-D., & Zhang, Y. (2016) · Scientific Reports · doi:10.1038/srep31651 · Cited by 86
Fang, C., Chen, Y., Wu, N., Yin, J., Li, X., Huang, H.-S., Zhang, W., Zhou, H., & Liu, Z. (2017) · Scientific Reports · doi:10.1038/srep40384 · Cited by 86
Fortunato, O., Boeri, M., Moro, M., Verri, C., Mensah, M., Conte, D., Caleca, L., Roz, L., Pastorino, U., & Sozzi, G. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.507 · Cited by 85
Sun, C., Li, S., Zhang, F., Zhang, Y., Zuo, Z., Xi, Y., Wang, L., & Li, D. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.96 · Cited by 85
MicroRNAs associated with therapy of non-small cell lung cancer
Lu, J., Zhan, Y., Feng, J., Luo, J., & Fan, S. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.22243 · Cited by 83
Fortunato, O., Borzi, C., Milione, M., Centonze, G., Conte, D., Boeri, M., Verri, C., Moro, M., Facchinetti, F., Andriani, F., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31988 · Cited by 83
Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer
Chen, X., Xu, Y., Liao, X., Liao, R., Zhang, L., Niu, K., Li, T., Li, D., Chen, Z., Duan, Y., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5052-8 · Cited by 82
Jiang, S., Wang, R., Yan, H., Jin, L., Dou, X., & Chen, D. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5010 · Cited by 81
microRNAs and lung cancer: tumors and 22-mers
Du, L., & Pertsemlidis, A. (2010) · Cancer Metastasis Review · doi:10.1007/s10555-010-9204-9 · Cited by 80
MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression
Kunita, A., Morita, S., Irisa, T. U., Goto, A., Niki, T., Takai, D., Nakajima, J., & Fukayama, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-27128-3 · Cited by 80
The proto-oncogene KRAS is targeted by miR-200c
Kopp, F. B., Wagner, E., & Roidl, A. (2013) · Oncotarget · doi:10.18632/oncotarget.1427 · Cited by 79
Halvorsen, A. R., Sandhu, V., Sprauten, M., Flote, V. G., Kure, E. H., Brustugun, O. T., & Helland, Å. (2018) · Acta Oncologica · doi:10.1080/0284186x.2018.1465585 · Cited by 78
miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes
Zhang, Y., Zhu, W., He, J.-Y., Chen, D., Huang, Y., Le, H., & Liu, X. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1240-0 · Cited by 76
miR‐134 inhibits non‐small cell lung cancer growth by targeting the epidermal growth factor receptor
Qin, Q., Wei, F., Zhang, J., Wang, X.-W., & Li, B. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12889 · Cited by 76
Zarogoulidis, P., Petanidis, S., Kioseoglou, E., Domvri, K., Anestakis, D., & Zarogoulidis, P. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.009 · Cited by 74
Association of Smoking, Alcohol Use, and Betel Quid Chewing with Epigenetic Aberrations in Cancers
Wang, T., Hsia, S., Shih, Y.-H., & Shieh, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061210 · Cited by 74
Li, J., GUAN, J., Long, X., Wang, Y., & Xiang, X. (2016) · Oncology Reports · doi:10.3892/or.2016.4714 · Cited by 73
In-Depth Analysis Shows Synergy between Erlotinib and miR-34a
Zhao, J. Y., Kelnar, K., & Bader, A. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089105 · Cited by 71
Wang, X., Chen, X., Meng, Q., Hu, J., Lu, H., Yang, Y., Li, C., & Zhao, Y. (2015) · Scientific Reports · doi:10.1038/srep17618 · Cited by 71
miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway
Han, J., Zhao, F., Zhang, J., Zhu, H., Ma, H., Li, X., Peng, L., Sun, J., & Chen, Z. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3401 · Cited by 68
Gyoba, J., Shan, S., Roa, W., & Bédard, E. L. R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040494 · Cited by 68
Jiang, W., Wei, K., Pan, C., Li, H., Cao, J., Han, X., Tang, Y., Zhu, S., Yuan, W., He, Y., et al. (2018) · Cell Proliferation · doi:10.1111/cpr.12502 · Cited by 67
MicroRNAs, Genomic Instability and Cancer
Vincent, K., Pichler, M., Lee, G., & Ling, H. Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150814475 · Cited by 66
Shen, H., Wang, L., Ge, X. Q., Jiang, C., Shi, Z., Li, D., Liu, W., Yu, X., & Shu, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.8011 · Cited by 66
Liu, M., Gao, J., Huang, Q., Jin, Y., & WEI, Z. (2016) · Oncology Letters · doi:10.3892/ol.2016.4468 · Cited by 66
Xie, Q., Yu, Z., Lu, Y., Fan, J., Ni, Y., & Ma, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27899 · Cited by 66
Zhao, J., Fu, W., Liao, H.-Y., Dai, L., Jiang, Z., Pan, Y., Huang, H., Mo, Y., Li, S., Yang, G., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1713-z · Cited by 65
Ding, G., Huang, G., Liu, H., Liang, H., Ni, Y., Ding, Z., Ni, G.-Y., & Hua, H.-W. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1795-3 · Cited by 65
Wang, Y.-Y., Ren, T., Cai, Y.-Y., & He, X. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1307 · Cited by 65
MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel
Liu, R., Liu, X., Zheng, Y., Gu, J., Xiong, S., Jiang, P., Jiang, X., Huang, E., YANG, Y., Ge, D., et al. (2014) · Oncology Letters · doi:10.3892/ol.2014.2500 · Cited by 60
MicroRNA‐31‐5p enhances the Warburg effect via targeting FIH
Zhu, B., Cao, X., Zhang, W., Pan, G., Yi, Q., Zhong, W., & Yan, D. (2018) · The FASEB Journal · doi:10.1096/fj.201800803r · Cited by 60
Up-regulation of microRNA-138 induce radiosensitization in lung cancer cells
Yang, H., Tang, Y., Guo, W., Du, Y., Wang, Y., Li, P., Zang, W., Yin, X., Wang, H., Chu, H., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-1879-z · Cited by 59
Li, J., Luo, N., Zhong, M., Xiao, Z., Wang, J., Yao, X., Peng, Y., & Cao, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-4017-7 · Cited by 59
MicroRNA 96 Is a Post-Transcriptional Suppressor of Anaplastic Lymphoma Kinase Expression
Vishwamitra, D., Li, Y., Wilson, D., Manshouri, R., Curry, C. V., Shi, B., Tang, X., Sheehan, A. M., Wistuba, I. I., Shi, P., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.008 · Cited by 58
Han, Z., Zhou, X., Li, S., Qin, Y., Chen, Y., & Liu, H. (2017) · Oncology Reports · doi:10.3892/or.2017.5938 · Cited by 58
miRNAs as biomarkers and for the early detection of non-small cell lung cancer (NSCLC)
Han, Y., & Li, H. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.05.32 · Cited by 58
Ye, Z., Yin, S., Su, Z., Bai, M., Zhang, H., Hei, Z., & Cai, S. (2016) · Oncotarget · doi:10.18632/oncotarget.6852 · Cited by 57
Shi, L., Xu, Z., Wu, G., Chen, X., Huang, Y., Wang, Y., Jiang, W., & Ke, B. (2017) · BMC Cancer · doi:10.1186/s12885-017-3132-9 · Cited by 57
Sehgal, K., Patell, R. D., Rangachari, D., & Costa, D. B. (2018) · Translational Cancer Research · doi:10.21037/tcr.2018.08.11 · Cited by 57
miR-130a regulates macrophage polarization and is associated with non-small cell lung cancer
Lin, L., Lin, H., Wang, L., Wang, B., Hao, X., & Shi, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.4301 · Cited by 56
MicroRNA-21 Regulates Non-Small Cell Lung Cancer Cell Invasion and Chemo-Sensitivity through SMAD7
Lin, L., Tu, H., Wu, L., Liu, M., & Jiang, G. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445571 · Cited by 53
Yin, J., Zhao, J., Hu, W., Yang, G., Yu, H. M., Wang, R., Wang, L., Zhang, G., Fu, W., Dai, L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172787 · Cited by 53
Du, X., Qi, F., Lu, S., Li, Y., & Han, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.113 · Cited by 52
Li, J., Han, L., Xu, Y. J., & Tao, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135265 · Cited by 51
Zhang, R., Liu, C., Niu, Y., Jing, Y., Zhang, H., Wang, J., Yang, J., Zen, K., Zhang, J., Zhang, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12300 · Cited by 51
Hashemi, Z. S., Khalili, S., Moghadam, M. F., & Sadroddiny, E. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1279403 · Cited by 51
Kim, H., Yang, J. M., Jin, Y., Jheon, S., Kim, K., Lee, C. T., Chung, J.-H., & Paik, J. H. (2016) · Oncotarget · doi:10.18632/oncotarget.14298 · Cited by 50
miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1
Su, W., Mo, Y., Wu, F., Guo, K., Li, J., Luo, Y., Ye, H., Guo, H., Li, D., & Yang, Z. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.027 · Cited by 49
Tumor suppressor miR-29c regulates radioresistance in lung cancer cells
Aréchaga-Ocampo, E., López‐Camarillo, C., Villegas‐Sepúlveda, N., la Rosa, C. H. G.-D., Perez‐Añorve, I. X., Roldan-Perez, R., Flores‐Pérez, A., Peña‐Curiel, O., Angeles‐Zaragoza, O., Rangel-Corona, R., et al. (2017) · Tumor Biology · doi:10.1177/1010428317695010 · Cited by 49
MicroRNA-targeted therapeutics for lung cancer treatment
Xue, J., Yang, J.-L., Luo, M., Cho, W., & Liu, X.-M. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1263298 · Cited by 47
Zhang, H., Hu, B., Wang, Z., Zhang, F., Wei, H., & Li, L. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3435-1 · Cited by 47
Zhang, J., Liu, J., Liu, Y., et al. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.08.013 · Cited by 46
Li, Y., HAN, W., Ni, T., LU, L., Huang, M., Zhang, Y., Cao, H., Zhang, H., Luo, W., & Li, H. (2015) · Oncology Reports · doi:10.3892/or.2015.3884 · Cited by 45
MicroRNA-449a Enhances Radiosensitivity in CL1-0 Lung Adenocarcinoma Cells
Liu, Y.-J., Lin, Y., Chen, Y., Luo, E., Sher, Y., Tsai, M., Chuang, E. Y.-Y., & Lai, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062383 · Cited by 45
Yu, S., Qin, X., Chen, T., Zhou, L., Xu, X., & Feng, J. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000524 · Cited by 45
Yun, M. R., Lim, S. M., Kim, S., Choi, H. M., Pyo, K., Kim, S. K., Lee, J. M., Lee, Y. W., Choi, J. W., Kim, H. R., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3146 · Cited by 45
Xie, J., Yu, F., Li, D., Zhu, X., Zhang, X., & Lv, Z. (2015) · Tumor Biology · doi:10.1007/s13277-015-3831-2 · Cited by 44
Genomic Sequence Analysis of EGFR Regulation by MicroRNAs in Lung Cancer
Chan, L., Wang, F., & Cho, W. C. S. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612800166747 · Cited by 42
Seviour, E. G., Sehgal, V., Mishra, D. K., Rupaimoole, R., Rodriguez‐Aguayo, C., Lopez‐Berestein, G., Lee, J. S., Sood, A. K., Kim, M. P., Mills, G. B., et al. (2016) · Oncogene · doi:10.1038/onc.2016.308 · Cited by 42
Zhao, J. Y., Guerrero, A., Kelnar, K., Peltier, H. J., & Bader, A. G. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.02.020 · Cited by 41
Goulart, B. H. L., & Ramsey, S. D. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0007 · Cited by 39
Nana-Sinkam, S. P., & Geraci, M. W. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31623-3 · Cited by 38
Zhai, S., Zhao, L., Lin, T. C., & Wang, W. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27961 · Cited by 38
miR-25 modulates NSCLC cell radio-sensitivity through directly inhibiting BTG2 expression
He, Z., Liu, Y., Xiao, B., & Qian, X. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.12.094 · Cited by 36
Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond
Karachaliou, N., Rosell, R., Morales-Espinosa, D., & Viteri, S. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2014.896210 · Cited by 36
Differential miRNA-Expression as an Adjunctive Diagnostic Tool in Neuroendocrine Tumors of the Lung
Demes, M. C., Aszyk, C. M., Bartsch, H., Schirren, J., & Fisseler‐Eckhoff, A. (2016) · Cancers · doi:10.3390/cancers8040038 · Cited by 34
miRNA-296-3p modulates chemosensitivity of lung cancer cells by targeting CX3CR1.
Luo, W., Lin, Y., Meng, S., Guo, Y., Zhang, J., & Zhang, W. (2016) · PubMed Central · Cited by 34
Advani, J., Subbannayya, Y., Patel, K., Khan, A. A., Patil, A. H., Jain, A., Solanki, H. S., Radhakrishnan, A., Pinto, S. M., Sahasrabuddhe, N. A., et al. (2017) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0045 · Cited by 32
Lu, L., Xu, H., Yang, P., Xue, J., Chen, C., Sun, Q., Yang, Q., Lü, J., Shi, A., & Liu, Q. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.02.027 · Cited by 31
Xu, T., Liao, Z. X., O’Reilly, M. S., Levy, L. B., Welsh, J. W., Wang, L., Lin, S. H., Komaki, R. R., Liu, Z., Wei, Q., et al. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.11.006 · Cited by 29
Tian, Y., Changyu, S., Limeng, Z., & Pan, Y. (2018) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2017.0182 · Cited by 29
Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond.
Karachaliou, N., & Rosell, R. (2014) · PubMed Central · doi:10.7497/j.issn.2095-3941.2014.03.003 · Cited by 28
Gao, H., Li, Y., Li, C., Zhao, L., & Liu, W. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5770 · Cited by 26
Chan, L., Wang, F., Meng, F., Wang, L., Wong, S. C. C., Au, J. S. K., Yang, S., & Cho, W. C. S. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00008 · Cited by 23
Bisagni, A., Pagano, M., Maramotti, S., Zanelli, F., Bonacini, M., Tagliavini, E., Braglia, L., Paci, M., Mozzarelli, A., & Croci, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196350 · Cited by 16
Wu, Y., Guo, L., Liu, J., Liu, R., Liu, M., & Chen, J. (2014) · 中国肺癌杂志 · doi:10.3779/j.issn.1009-3419.2014.01.01 · Cited by 15
Differential MicroRNA Expression between EGFR T790M and L858R Mutated Lung Cancer
Kim, J. Y., Lee, W. J., Park, H. Y., Kim, A., Shin, D., & Lee, C. H. (2018) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2018.07.29 · Cited by 7
Cited by
Sex differences in cancer mechanisms
Rubin, J. B., Lagas, J. S., Broestl, L., Sponagel, J., Rockwell, N., Rhee, G., Rosen, S. F., Chen, S., Klein, R. S., Imoukhuede, P., et al. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00291-x · Cited by 366
The role of HPV gene expression and selected cellular MiRNAs in lung cancer development
Hussen, B. M., Ahmadi, G., Marzban, H., Fard Azar, M. E., Sorayyayi, S., Karampour, R., Nahand, J. S., Hidayat, H. J., & Moghoofei, M. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104692 · Cited by 62
Oxidative stress in lung cancer
Mousapasandi, A., Loke, W. S. J., Herbert, C. A., & Thomas, P. S. (2021) · Cancer · doi:10.1016/b978-0-12-819547-5.00003-1 · Cited by 5
Metadata
- Authors
- Wu, K.-L., Tsai, Y.-M., Lien, C.-T., Kuo, P.-L., & Hung, J.-Y.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-03-31
- Volume
- 20
- Issue
- 7
- Pages
- 1611
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2929491112
- Cited by
- 284
- References
- 161
- FWCI
- 12.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.